103 related articles for article (PubMed ID: 10808369)
1. p185HER2 overexpression in human breast cancer using molecular and immunohistochemical methods.
Johnson RC; Ricci A; Cartun RW; Ackroyd R; Tsongalis GJ
Cancer Invest; 2000; 18(4):336-42. PubMed ID: 10808369
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF
Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889
[TBL] [Abstract][Full Text] [Related]
3. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
4. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
López-Guerrero JA; Navarro S; Noguera R; Almenar S; Pellin A; Vázquez C; Llombart-Bosch A
Arkh Patol; 2003; 65(1):50-5. PubMed ID: 12669615
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies.
de Cremoux P; Martin EC; Vincent-Salomon A; Dieras V; Barbaroux C; Liva S; Pouillart P; Sastre-Garau X; Magdelenat H
Int J Cancer; 1999 Oct; 83(2):157-61. PubMed ID: 10471520
[TBL] [Abstract][Full Text] [Related]
6. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
7. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays.
McCormick SR; Lillemoe TJ; Beneke J; Schrauth J; Reinartz J
Am J Clin Pathol; 2002 Jun; 117(6):935-43. PubMed ID: 12047146
[TBL] [Abstract][Full Text] [Related]
8. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
Kobayashi M; Ooi A; Oda Y; Nakanishi I
Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
[TBL] [Abstract][Full Text] [Related]
9. Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2.
Gerdes AM; Nielsen O; Mohr U; Pfeiffer P; Knoop A; Rose C; Hørder M; Clausen PP
Anticancer Res; 1998; 18(4A):2529-34. PubMed ID: 9703905
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the HER2/neu gene amplification in microdissected breast cancer tumour samples.
Seth RM; Burger AM; Kahn HJ
Anticancer Res; 2006; 26(2A):927-31. PubMed ID: 16619488
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
Lottner C; Schwarz S; Diermeier S; Hartmann A; Knuechel R; Hofstaedter F; Brockhoff G
J Pathol; 2005 Apr; 205(5):577-84. PubMed ID: 15732132
[TBL] [Abstract][Full Text] [Related]
12. HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
Pritchard KI; Shepherd LE; O'Malley FP; Andrulis IL; Tu D; Bramwell VH; Levine MN;
N Engl J Med; 2006 May; 354(20):2103-11. PubMed ID: 16707747
[TBL] [Abstract][Full Text] [Related]
13. Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.
Motomura K; Koyama H; Noguchi S; Inaji H; Azuma C
Breast Cancer Res Treat; 1995; 33(1):89-92. PubMed ID: 7749137
[TBL] [Abstract][Full Text] [Related]
14. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
Erdogan S; Ergin M; Tuncer I
Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
[TBL] [Abstract][Full Text] [Related]
15. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
16. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.
Vanden Bempt I; Van Loo P; Drijkoningen M; Neven P; Smeets A; Christiaens MR; Paridaens R; De Wolf-Peeters C
J Clin Oncol; 2008 Oct; 26(30):4869-74. PubMed ID: 18794552
[TBL] [Abstract][Full Text] [Related]
17. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
Mrhalová M; Kodet R; Kalinová M; Hilská I
Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
[TBL] [Abstract][Full Text] [Related]
18. An improved method for semiquantification of gene amplification from archival material.
Underwood MA; Bartlett JM; Cooke TG
PCR Methods Appl; 1994 Dec; 4(3):178-84. PubMed ID: 7580903
[TBL] [Abstract][Full Text] [Related]
19. Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.
Bánkfalvi A; Simon R; Brandt B; Bürger H; Vollmer I; Dockhorn-Dworniczak B; Lellé RJ; Boecker W
Histopathology; 2000 Nov; 37(5):411-9. PubMed ID: 11119122
[TBL] [Abstract][Full Text] [Related]
20. p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.
Dalifard I; Daver A; Goussard J; Lorimier G; Gosse-Brun S; Lortholary A; Larra F
Int J Mol Med; 1998 May; 1(5):855-61. PubMed ID: 9852307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
